dc.contributor.author
Irmer, Marie Luise
dc.contributor.author
Nast, Alexander
dc.contributor.author
Ghoreschi, Franziska
dc.contributor.author
Vogt, Annika
dc.contributor.author
Ghoreschi, Kamran
dc.date.accessioned
2025-03-24T13:08:21Z
dc.date.available
2025-03-24T13:08:21Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/47009
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-46724
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
research support, non-U.S. Gov't
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Severe bullous drug reaction after COVID‐19 mRNA vaccination
dc.type
Letter to the Editor
dcterms.bibliographicCitation.doi
10.1111/ddg.14867
dcterms.bibliographicCitation.journaltitle
JDDG: Journal der Deutschen Dermatologischen Gesellschaft
dcterms.bibliographicCitation.number
11
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.pagestart
1509
dcterms.bibliographicCitation.pageend
1511
dcterms.bibliographicCitation.volume
20
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
36259242
dcterms.isPartOf.issn
1610-0379
dcterms.isPartOf.eissn
1610-0387
